Carol Feghali-Bostwick, PhD, joined the Division of Rheumatology and Immunology effective October 1, 2013, as the Kitty Trask Holt Endowed Chair and Professor of Medicine. Dr. Feghali-Bostwick earned her Master of Science from the American University of Beirut in Beirut, Lebanon with a major in Microbiology. She completed her PhD in Microbiology and Immunology at Tulane University in New Orleans, LA.
Dr. Feghali-Bostwick leads a team of clinical and basic scientists whose goal is to identify novel targets for therapy and develop new anti-fibrotic strategies for scleroderma and other fibrosing conditions. Dr. Feghali-Bostwick also contributes to the mentoring of young physician and academic scientists.
Work in the Feghali-Bostwick laboratory has been supported by grants from the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases; SmartState SC Centers of Economic Excellence; and Biogen Idec, MA, Inc.